Hypertrophic cardiomyopathy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged >= 18 years at inclusion; 2. Patients with maximal left ventricle wall thickness =15 mm measurement by echocardiography and/or cardiac magnetic resonance imaging or =13 mm for individuals with family history of HCM;3.Written, voluntary informed consent to participate in the study.
Exclusion criteria
Exclusion criteria: 1.Patients with severe valvular heart disease,congenital heart disease,hypertensive heart disease or other cardiac or systemic diseases capable of producing left ventricle hypertrophy;2.Life expectancy less than 12 months;3.Without written informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| All cause death, cardiovascular death and other adverse cardiovascular events; | — |
Secondary
| Measure | Time frame |
|---|---|
| Cardiac structural changes, peak oxygen consumption in cardiopulmonary exercise testing,NYHA cardiac functional class and admission for heart failure ; | — |
Countries
China
Contacts
Department of Cardiology, Xiaoqiao Hospital, Chongqing, China